Novozymes AS (NVZMF)
Novozymes A/S is a Denmark-based company listed on OTC Markets as common stock. It develops and sells industrial enzymes, functional proteins, and microorganisms used across a wide range of applications. Its solutions support food and beverage production, including dairy, baking, beverages, meat, plant-based products, and other nutrition categories, as well as areas such as bioenergy, household and institutional cleaning, and human health. The company also provides products and technologies for agriculture, animal nutrition, leather and textiles, starch and grain processing, sustainable plastics, oils and fats, and other industrial uses. Novozymes serves customers in Denmark, the rest of Europe, North America, Asia Pacific, the Middle East, Africa, and Latin America, and is headquartered in Lyngby, Denmark.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-NVZM.F
|
$61.43
|
-4.3% Downside
|
Fair
|
—
|
—
|
—
|
Good
|
—
|
—
|
1.01
|
1.5%
|
August 20, 2026
|
44.2x
|
2.4x
|
6.3x
|
30.15 B
|
33.84 B
|
10.8%
|
74.4%
|
14.2
|
111.9%
|
140.6%
|
